Description
Retinagenix is a biotechnology company, developing and commercializing synthetic retinoids for treatment of retinal diseases.
Team Members
David Saperstein
Co-founder and Chief Medical Officer, and former professor of ophthalmology at University of Washington
Krzysztof Palczewski
Co-founder and John H. Hord Professor and Chair Department of Pharmacology